Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-015921

CEO and CFO bought 9,250 shares at $8.35 ($77,238)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2022-06-03 Purchase +9,250 $8.35 $77,238 1,232,953 D
Open-market purchases · 9,250 sh · avg $8.35 · $77,238
Loading xslF345X03/ownership.xml…